Cargando…
Mass campaigns combining antimalarial drugs and anti-infective vaccines as seasonal interventions for malaria control, elimination and prevention of resurgence: a modelling study
BACKGROUND: The only licensed malaria vaccine, RTS,S/AS01, has been developed for morbidity-control in young children. The potential impact on transmission of deploying such anti-infective vaccines to wider age ranges, possibly with co-administration of antimalarial treatment, is unknown. Combinatio...
Autores principales: | Camponovo, Flavia, Ockenhouse, Chris F., Lee, Cynthia, Penny, Melissa A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6820916/ https://www.ncbi.nlm.nih.gov/pubmed/31664924 http://dx.doi.org/10.1186/s12879-019-4467-4 |
Ejemplares similares
-
Resurgent and delayed malaria
por: Greenwood, Brian, et al.
Publicado: (2022) -
Future use-cases of vaccines in malaria control and elimination
por: Penny, Melissa A., et al.
Publicado: (2020) -
Resurgence of malaria infection after mass treatment: a simulation study
por: Smith, Thomas A., et al.
Publicado: (2019) -
Mass campaigns with antimalarial drugs: a modelling comparison of artemether-lumefantrine and DHA-piperaquine with and without primaquine as tools for malaria control and elimination
por: Gerardin, Jaline, et al.
Publicado: (2015) -
Combining antimalarial drugs and vaccine for malaria elimination campaigns: a randomized safety and immunogenicity trial of RTS,S/AS01 administered with dihydroartemisinin, piperaquine, and primaquine in healthy Thai adult volunteers
por: von Seidlein, Lorenz, et al.
Publicado: (2019)